Go Pro
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel Free SRTS Stock Alerts

Sensus Healthcare (SRTS) Financials

Sensus Healthcare logo
$3.02 -0.06 (-1.95%)
Closing price 07/16/2026 04:00 PM Eastern
Extended Trading
$3.02 0.00 (-0.17%)
As of 07/16/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Sensus Healthcare

Annual Income Statements for Sensus Healthcare

This table shows Sensus Healthcare's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -0.75 -0.35 -3.71 -2.02 -1.70 -6.84 4.12 23 0.49 6.65 -7.72
Consolidated Net Income / (Loss)		 -0.24 -0.35 -3.71 -2.02 -1.70 -6.84 4.12 24 0.49 6.65 -7.72
Net Income / (Loss) Continuing Operations		 -0.24 -0.35 -3.71 -2.02 -1.70 -6.84 4.12 23 0.49 6.65 -7.72
Total Pre-Tax Income 		-0.24 -0.35 -3.71 -2.02 -1.70 -6.84 4.12 28 0.65 9.02 -9.62
Total Operating Income		 -0.22 -0.36 -3.72 -2.01 -1.97 -8.23 4.12 15 -0.38 8.09 -10
Total Gross Profit		 6.58 9.85 14 17 18 5.25 17 30 14 24 12
Total Revenue		 10 15 21 26 27 9.58 27 45 24 42 27
Operating Revenue		 10 15 21 26 27 9.58 27 45 24 42 27
Total Cost of Revenue		 3.69 4.97 6.79 9.52 9.71 4.33 10 15 10 17 16
Operating Cost of Revenue		 3.69 4.97 6.79 9.52 9.71 4.33 10 15 10 17 16
Total Operating Expenses		 6.80 10 18 19 20 13 13 17 14 16 22
Selling, General & Admin Expense		 1.59 3.47 3.72 4.12 4.00 3.99 4.59 5.01 5.16 7.15 7.87
Marketing Expense		 3.75 4.92 8.31 8.53 9.10 5.34 4.84 6.33 5.61 4.98 6.52
Research & Development Expense		 1.47 1.82 5.49 6.26 6.42 4.16 3.44 3.46 3.68 4.22 7.78
Total Other Income / (Expense), net		 -0.02 0.02 0.01 -0.02 0.27 1.40 -0.00 14 1.03 0.93 0.68
Interest Expense		 0.02 0.02 0.07 0.16 0.00 -0.74 0.00 -0.38 -0.99 -0.93 -0.68
Income Tax Expense		 0.00 - - - - - 0.00 3.75 0.17 2.38 -1.91
Basic Earnings per Share		 ($0.08) ($0.03) ($0.28) ($0.14) ($0.10) ($0.42) $0.25 $1.47 $0.03 $0.41 ($0.47)
Weighted Average Basic Shares Outstanding		 9.89M 12.03M 13.24M 14.12M 16.23M 16.43M 16.48M 16.48M 16.26M 16.31M 16.33M
Diluted Earnings per Share		 ($0.08) ($0.03) ($0.28) ($0.14) ($0.10) ($0.42) $0.25 $1.46 $0.03 $0.41 ($0.47)
Weighted Average Diluted Shares Outstanding		 9.89M 12.03M 13.24M 14.12M 16.23M 16.43M 16.50M 16.62M 16.27M 16.36M 16.33M
Weighted Average Basic & Diluted Shares Outstanding		 9.89M 12.03M 13.24M 14.12M 16.23M 16.43M 16.66M 16.40M 16.39M 16.50M 16.46M

Quarterly Income Statements for Sensus Healthcare

This table shows Sensus Healthcare's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -1.45 4.21 2.27 1.61 1.22 1.55 -2.57 -1.04 -0.94 -3.17 -2.63
Consolidated Net Income / (Loss)		 -1.45 4.21 2.27 1.61 1.22 1.55 -2.57 -1.04 -0.94 -3.17 -2.63
Net Income / (Loss) Continuing Operations		 -1.45 4.21 2.27 1.61 1.22 1.55 -2.57 -1.04 -0.94 -3.17 -2.63
Total Pre-Tax Income 		-1.58 5.81 3.10 2.19 1.77 1.96 -2.46 -1.76 -2.41 -2.99 -4.23
Total Operating Income		 -1.90 5.58 2.89 1.98 1.50 1.73 -2.65 -1.94 -2.57 -3.15 -4.36
Total Gross Profit		 1.99 7.83 6.66 5.42 5.24 7.11 4.35 2.90 2.71 1.90 0.99
Total Revenue		 3.90 13 11 9.24 8.84 13 8.34 7.32 6.88 4.94 3.39
Operating Revenue		 3.90 13 11 9.24 8.84 13 8.34 7.32 6.88 4.94 3.39
Total Cost of Revenue		 1.91 4.74 4.00 3.82 3.60 5.96 3.99 4.41 4.17 3.04 2.40
Operating Cost of Revenue		 1.91 4.74 4.00 3.82 3.60 5.96 3.99 4.41 4.17 3.04 2.40
Total Operating Expenses		 3.88 2.25 3.78 3.44 3.75 5.38 7.00 4.85 5.28 5.05 5.35
Selling, General & Admin Expense		 1.51 0.95 1.58 1.58 1.57 2.42 2.21 1.99 1.92 1.76 2.04
Marketing Expense		 1.29 0.62 1.27 1.00 1.31 1.40 2.19 1.39 1.55 1.40 1.72
Research & Development Expense		 1.08 0.68 0.93 0.87 0.86 1.56 2.61 1.47 1.82 1.88 1.59
Total Other Income / (Expense), net		 0.32 0.23 0.21 0.21 0.28 0.23 0.18 0.18 0.16 0.16 0.13
Interest Expense		 - - -0.21 -0.21 -0.28 -0.23 -0.18 -0.18 -0.16 -0.16 -0.13
Income Tax Expense		 -0.13 1.60 0.83 0.58 0.56 0.41 0.11 -0.72 -1.47 0.17 -1.61
Basic Earnings per Share		 ($0.09) $0.26 $0.14 $0.10 $0.07 $0.10 ($0.16) ($0.06) ($0.06) ($0.19) ($0.16)
Weighted Average Basic Shares Outstanding		 16.27M 16.26M 16.29M 16.30M 16.32M 16.31M 16.34M 16.32M 16.32M 16.33M 16.46M
Diluted Earnings per Share		 ($0.09) $0.26 $0.14 $0.10 $0.07 $0.10 ($0.16) ($0.06) ($0.06) ($0.19) ($0.16)
Weighted Average Diluted Shares Outstanding		 16.27M 16.27M 16.32M 16.33M 16.35M 16.36M 16.34M 16.32M 16.32M 16.33M 16.46M
Weighted Average Basic & Diluted Shares Outstanding		 16.38M 16.39M 16.39M 16.39M - 16.50M 16.45M 16.44M 16.43M 16.46M 16.46M

Annual Cash Flow Statements for Sensus Healthcare

This table details how cash moves in and out of Sensus Healthcare's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 0.53 -0.02 5.04 2.40 -4.38 6.81 -0.39 11 -2.37 -1.09 0.03
Net Cash From Operating Activities		 -1.34 -3.85 -3.06 -8.56 -2.11 -0.43 -0.29 -1.41 -2.15 -0.83 0.53
Net Cash From Continuing Operating Activities		 -1.34 -0.85 -3.06 -8.56 -2.11 -0.43 -0.29 -1.41 -2.15 -0.83 0.53
Net Income / (Loss) Continuing Operations		 -0.24 -0.35 -3.71 -2.02 -1.70 -6.84 4.12 24 0.49 6.65 -7.72
Consolidated Net Income / (Loss)		 -0.24 -0.35 -3.71 -2.02 -1.70 -6.84 4.12 24 0.49 6.65 -7.72
Depreciation Expense		 0.32 0.34 0.39 0.66 0.55 0.72 0.61 0.32 0.28 0.24 0.39
Amortization Expense		 - - - - - - - 0.19 0.19 0.19 0.24
Non-Cash Adjustments To Reconcile Net Income		 0.04 0.76 0.83 1.09 1.35 10 -7.31 -12 0.23 0.52 0.04
Changes in Operating Assets and Liabilities, net		 -1.46 -4.60 -0.57 -8.29 -2.30 -4.39 2.29 -15 -3.32 -8.43 7.58
Net Cash From Investing Activities		 -0.20 -7.85 6.17 -2.64 -4.90 7.03 0.13 15 -0.19 -0.28 -0.20
Net Cash From Continuing Investing Activities		 -0.20 -7.85 6.17 -2.64 -4.90 7.03 0.13 15 -0.19 -0.28 -0.20
Purchase of Property, Plant & Equipment		 -0.20 -0.29 -0.29 -0.85 -0.40 -0.36 -0.13 -0.16 -0.23 -0.28 -0.20
Net Cash From Financing Activities		 2.06 8.68 1.93 14 2.62 0.21 -0.23 -2.43 -0.04 0.02 -0.31
Net Cash From Continuing Financing Activities		 2.06 8.68 1.93 14 2.62 0.21 -0.23 -2.43 -0.04 0.02 -0.31
Repurchase of Common Equity		 -0.19 -2.13 0.00 -1.40 - - 0.00 -3.00 -0.03 0.00 -0.30
Other Financing Activities, net		 - 0.00 -0.29 -0.03 2.62 -0.06 -0.02 0.62 -0.01 0.02 -0.01
Cash Interest Paid		 0.02 0.02 0.04 0.16 0.00 0.01 0.00 0.00 0.00 0.00 0.00
Cash Income Taxes Paid		 - - - - - - 0.00 4.57 1.44 2.58 0.98

Quarterly Cash Flow Statements for Sensus Healthcare

This table details how cash moves in and out of Sensus Healthcare's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 0.43 2.66 -8.42 4.24 3.59 -0.50 -2.98 3.09 2.29 -2.37 -3.76
Net Cash From Operating Activities		 0.44 2.67 -8.19 4.23 3.95 -0.83 -2.68 3.12 2.30 -2.21 -3.75
Net Cash From Continuing Operating Activities		 0.44 2.67 -8.19 4.23 3.95 -0.83 -2.68 3.12 2.30 -2.21 -3.75
Net Income / (Loss) Continuing Operations		 -1.45 4.21 2.27 1.61 1.22 1.55 -2.57 -1.04 -0.94 -3.17 -2.63
Consolidated Net Income / (Loss)		 -1.45 4.21 2.27 1.61 1.22 1.55 -2.57 -1.04 -0.94 -3.17 -2.63
Depreciation Expense		 0.06 0.06 0.07 0.03 0.05 0.09 0.09 0.10 0.10 0.10 0.10
Amortization Expense		 0.05 0.05 0.05 0.05 0.05 0.05 0.06 0.06 0.06 0.06 0.06
Non-Cash Adjustments To Reconcile Net Income		 0.07 -0.34 0.24 0.14 -0.38 0.52 -0.02 -0.16 0.52 -0.45 -0.01
Changes in Operating Assets and Liabilities, net		 1.72 -1.31 -11 2.40 3.02 -3.02 -0.24 4.15 2.56 1.24 -1.28
Net Cash From Investing Activities		 0.03 - -0.23 -0.00 -0.34 0.30 -0.01 -0.03 -0.00 -0.16 -0.00
Net Cash From Continuing Investing Activities		 0.03 - -0.23 -0.00 -0.34 0.30 -0.01 -0.03 -0.00 -0.16 -0.00
Purchase of Property, Plant & Equipment		 -0.01 - -0.23 -0.00 -0.34 0.30 -0.01 -0.03 -0.00 -0.16 -0.00
Net Cash From Financing Activities		 -0.04 -0.01 0.00 0.02 -0.03 0.03 -0.30 - - -0.01 0.00
Net Cash From Continuing Financing Activities		 -0.04 -0.01 0.00 0.02 -0.03 0.03 -0.30 - - -0.01 0.00
Repurchase of Common Equity		 - - 0.00 - -0.05 0.05 -0.30 - - - 0.00
Cash Interest Paid		 - - 0.00 - - - 0.00 - - - 0.00
Cash Income Taxes Paid		 0.05 - 0.00 0.94 1.54 0.11 0.00 0.98 0.00 - 0.00

Annual Balance Sheets for Sensus Healthcare

This table presents Sensus Healthcare's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 9.64 19 19 33 37 28 32 57 54 62 53
Total Current Assets		 8.57 17 18 32 34 25 31 53 50 57 46
Cash & Equivalents		 5.07 5.04 10 12 8.10 15 15 26 23 22 22
Accounts Receivable		 2.07 3.10 4.96 13 14 3.78 12 17 11 20 6.04
Inventories, net		 1.00 1.25 1.17 1.63 3.00 4.43 1.76 3.50 12 10 15
Prepaid Expenses		 0.43 0.90 0.57 1.75 1.51 2.06 2.84 6.26 2.99 3.35 1.52
Other Current Assets		 - - - - - - - 0.66 0.89 1.51 1.68
Plant, Property, & Equipment, net		 0.32 0.43 0.39 0.89 1.08 1.36 0.77 1.24 0.46 2.00 1.98
Total Noncurrent Assets		 0.75 1.75 0.55 0.46 1.84 1.48 0.22 2.26 3.72 3.43 5.17
Noncurrent Deferred & Refundable Income Taxes		 - - - - - - 0.00 1.71 2.14 2.20 4.08
Other Noncurrent Operating Assets		 0.02 0.02 0.02 0.02 1.50 1.15 0.08 0.54 1.58 1.23 1.09
Total Liabilities & Shareholders' Equity		 9.64 19 19 33 37 28 32 57 54 62 53
Total Liabilities		 3.71 3.67 7.15 6.79 8.92 6.51 6.23 8.67 4.87 6.34 4.94
Total Current Liabilities		 3.67 3.66 4.87 6.02 6.47 4.86 5.96 7.70 4.21 5.89 4.72
Accounts Payable		 2.31 2.76 4.07 5.17 4.78 2.87 4.06 5.52 2.79 4.81 3.34
Accrued Expenses		 0.05 0.04 0.15 0.14 0.19 0.19 0.51 0.40 0.54 0.33 0.28
Current Deferred Revenue		 0.89 0.85 0.65 0.72 1.19 1.49 1.17 0.69 0.66 0.54 0.84
Other Current Liabilities		 - - - 0.00 0.31 0.30 0.17 0.19 0.19 0.20 0.26
Total Noncurrent Liabilities		 0.05 0.02 2.29 0.77 2.45 1.66 0.26 0.97 0.66 0.45 0.22
Noncurrent Deferred Revenue		 0.05 0.02 0.07 0.77 1.34 0.58 0.26 0.14 0.06 0.06 0.01
Other Noncurrent Operating Liabilities		 - - - 0.00 1.12 0.81 0.00 - 0.60 0.40 0.21
Commitments & Contingencies		 - - - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 5.92 15 12 26 28 21 26 48 49 56 48
Total Preferred & Common Equity		 5.92 15 12 26 28 21 26 48 49 56 48
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 5.92 15 12 26 28 21 26 48 49 56 48
Common Stock		 13 23 23 40 43 44 44 45 46 46 46
Retained Earnings		 -7.45 -7.79 -12 -14 -15 -22 -18 6.30 6.79 13 5.72
Treasury Stock		 - 0.00 -0.13 -0.13 -0.25 -0.31 -0.33 -3.43 -3.52 -3.57 -3.88

Quarterly Balance Sheets for Sensus Healthcare

This table presents Sensus Healthcare's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 51 57 58 60 60 59 58 52
Total Current Assets		 46 54 54 55 54 52 50 43
Cash & Equivalents		 20 15 19 23 19 22 24 18
Accounts Receivable		 6.88 20 18 17 18 13 9.34 3.58
Inventories, net		 13 15 13 12 9.92 12 13 17
Prepaid Expenses		 3.95 3.67 3.33 1.72 5.65 2.68 1.34 2.48
Other Current Assets		 1.34 1.17 1.11 1.60 1.53 2.35 2.04 1.71
Plant, Property, & Equipment, net		 1.24 1.36 0.71 1.64 2.68 2.71 2.52 2.31
Total Noncurrent Assets		 3.45 2.00 2.98 3.42 3.34 3.92 5.57 6.64
Noncurrent Deferred & Refundable Income Taxes		 3.14 1.31 1.64 2.20 2.09 2.81 4.24 5.69
Other Noncurrent Operating Assets		 0.31 0.69 1.33 1.22 1.25 1.11 1.33 0.96
Total Liabilities & Shareholders' Equity		 51 57 58 60 60 59 58 52
Total Liabilities		 5.96 6.07 5.26 5.73 7.18 6.79 7.10 6.00
Total Current Liabilities		 5.23 5.47 4.68 5.21 6.73 6.41 6.80 5.86
Accounts Payable		 4.00 3.70 3.28 3.97 5.64 5.37 5.62 4.69
Accrued Expenses		 0.34 0.59 0.52 0.35 0.29 0.27 0.28 0.26
Current Deferred Revenue		 0.71 0.95 0.69 0.69 0.55 0.53 0.65 0.64
Other Current Liabilities		 0.18 0.19 0.20 0.20 0.25 0.25 0.26 0.27
Total Noncurrent Liabilities		 0.73 0.59 0.58 0.52 0.45 0.38 0.30 0.15
Noncurrent Deferred Revenue		 0.08 0.04 0.08 0.07 0.04 0.03 0.02 0.00
Other Noncurrent Operating Liabilities		 0.65 - 0.50 0.45 0.41 0.34 0.28 0.14
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 45 51 53 54 53 52 51 46
Total Preferred & Common Equity		 45 51 53 54 53 52 51 46
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 45 51 53 54 53 52 51 46
Common Stock		 46 46 46 46 46 46 46 46
Retained Earnings		 2.58 9.06 11 12 11 9.83 8.88 3.09
Treasury Stock		 -3.51 -3.52 -3.52 -3.57 -3.87 -3.87 -3.87 -3.88

Annual Metrics And Ratios for Sensus Healthcare

This table displays calculated financial ratios and metrics derived from Sensus Healthcare's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 0.00 13,546,170.00 13,488,714.00 16,085,461.00 16,497,030.00 16,502,353.00 16,617,274.00 16,612,105.00 16,382,404.00 16,382,404.00 16,425,036.00
DEI Adjusted Shares Outstanding		 0.00 13,546,170.00 13,488,714.00 16,085,461.00 16,497,030.00 16,502,353.00 16,617,274.00 16,612,105.00 16,382,404.00 16,382,404.00 16,425,036.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 -0.03 -0.28 -0.13 -0.10 -0.41 0.25 1.36 0.03 0.41 -0.47
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 44.17% 39.00% 28.36% 3.16% -64.87% 182.36% 64.68% -45.20% 71.31% -34.26%
EBITDA Growth		 0.00% -127.07% -12,938.55% 59.54% -5.60% -386.72% 168.34% 502.26% -99.58% 6,942.98% -213.60%
EBIT Growth		 0.00% -64.12% -923.75% 46.06% 1.85% -288.46% 153.87% 579.53% -101.21% 2,479.41% -227.40%
NOPAT Growth		 0.00% -64.12% -923.75% 46.06% 1.85% -318.33% 171.48% 211.80% -102.21% 2,197.56% -221.05%
Net Income Growth		 0.00% -46.02% -971.02% 45.49% 15.96% -302.12% 160.25% 488.59% -98.00% 1,270.52% -216.13%
EPS Growth		 0.00% 62.50% -833.33% 50.00% 28.57% -320.00% 159.52% 484.00% -97.95% 1,266.67% -214.63%
Operating Cash Flow Growth		 0.00% -187.61% 20.65% -180.17% 75.40% 79.40% 34.10% -393.71% -51.91% 61.26% 163.54%
Free Cash Flow Firm Growth		 0.00% 0.00% -61.04% -270.29% 71.32% 96.15% -428.35% 277.60% -356.30% 18.56% 125.56%
Invested Capital Growth		 0.00% 108.37% 1.48% 309.72% 12.89% -45.20% 68.42% 102.47% 9.90% 31.44% -22.97%
Revenue Q/Q Growth		 0.00% 0.00% 8.38% 6.49% 1.60% -26.28% 41.49% 0.18% -2.16% 1.21% -22.82%
EBITDA Q/Q Growth		 0.00% 0.00% -14.03% 29.62% 37.48% -0.48% 2,130.90% 74.18% 109.20% -30.98% -100.19%
EBIT Q/Q Growth		 0.00% 0.00% -12.68% 17.63% 32.63% -1.87% 536.80% 75.16% 81.02% -32.26% -89.75%
NOPAT Q/Q Growth		 0.00% 0.00% -12.68% 17.63% 32.63% -9.70% 724.15% -13.09% 77.33% -31.01% -89.75%
Net Income Q/Q Growth		 0.00% 0.00% -13.51% 20.15% 35.54% -0.32% 2,363.19% -9.31% 154.13% -28.61% -156.79%
EPS Q/Q Growth		 0.00% 0.00% -12.00% 22.22% 33.33% 0.00% 1,350.00% 0.00% 0.00% -28.07% -161.11%
Operating Cash Flow Q/Q Growth		 0.00% -58.82% 43.02% -40.01% 50.07% -212.46% -125.22% -120.40% 85.63% -131.19% -72.33%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% -39.30% 42.64% -107.95% -273.43% -89.39% 83.56% -281.53% -47.45%
Invested Capital Q/Q Growth		 0.00% 0.00% -28.04% 22.10% 4.93% 29.11% 167.23% 144.88% 6.61% 6.96% -2.71%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 64.05% 66.48% 67.03% 63.99% 64.40% 54.81% 62.82% 66.53% 57.61% 58.44% 43.18%
EBITDA Margin		 0.92% -0.17% -16.17% -5.10% -5.22% -72.30% 17.50% 64.00% 0.50% 20.38% -35.23%
Operating Margin		 -2.15% -2.45% -18.06% -7.59% -7.22% -85.98% 15.24% 33.30% -1.57% 19.35% -37.50%
EBIT Margin		 -2.15% -2.45% -18.06% -7.59% -7.22% -79.84% 15.23% 62.85% -1.39% 19.35% -37.50%
Profit (Net Income) Margin		 -2.31% -2.34% -18.02% -7.65% -6.24% -71.38% 15.23% 54.44% 1.99% 15.90% -28.09%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 86.62% 74.39% 73.68% 80.21%
Interest Burden Percent		 107.24% 95.41% 99.81% 100.87% 86.37% 89.41% 100.00% 100.00% -191.76% 111.52% 93.37%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 13.38% 25.61% 26.32% 0.00%
Return on Invested Capital (ROIC)		 -12.11% -12.89% -96.90% -20.36% -11.68% -59.52% 44.78% 73.56% -1.16% 20.05% -24.14%
ROIC Less NNEP Spread (ROIC-NNEP)		 -10.33% -11.82% -86.63% -15.28% -9.59% -52.40% 44.78% 15.35% -4.37% 17.01% -21.85%
Return on Net Nonoperating Assets (RNNOA)		 8.10% 9.62% 69.37% 9.75% 5.44% 31.90% -27.44% -8.11% 2.16% -7.35% 9.28%
Return on Equity (ROE)		 -4.01% -3.27% -27.53% -10.61% -6.24% -27.62% 17.34% 65.45% 1.00% 12.70% -14.85%
Cash Return on Invested Capital (CROIC)		 0.00% -83.17% -98.38% -141.89% -23.78% -1.12% -6.21% 5.81% -10.59% -7.12% 1.81%
Operating Return on Assets (OROA)		 -2.30% -2.54% -19.68% -7.70% -5.61% -23.55% 13.67% 62.92% -0.62% 13.96% -17.89%
Return on Assets (ROA)		 -2.46% -2.42% -19.64% -7.77% -4.85% -21.06% 13.67% 54.50% 0.88% 11.47% -13.40%
Return on Common Equity (ROCE)		 -4.01% -3.27% -27.53% -10.61% -6.24% -27.62% 17.34% 65.45% 1.00% 12.70% -14.85%
Return on Equity Simple (ROE_SIMPLE)		 -4.01% -2.27% -31.77% -7.64% -6.07% -31.80% 15.83% 50.44% 0.99% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -0.15 -0.25 -2.60 -1.40 -1.38 -5.76 4.12 13 -0.28 5.96 -7.21
NOPAT Margin		 -1.51% -1.72% -12.64% -5.31% -5.05% -60.18% 15.24% 28.85% -1.16% 14.26% -26.25%
Net Nonoperating Expense Percent (NNEP)		 -1.77% -1.07% -10.27% -5.08% -2.09% -7.12% -0.01% 58.21% 3.22% 3.04% -2.28%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -0.58% 10.68% -15.00%
Cost of Revenue to Revenue		 35.95% 33.52% 32.97% 36.01% 35.60% 45.19% 37.18% 33.47% 42.39% 41.56% 56.82%
SG&A Expenses to Revenue		 15.44% 23.42% 18.08% 15.61% 14.69% 41.65% 16.99% 11.25% 21.13% 17.10% 28.65%
R&D to Revenue		 14.28% 12.32% 26.67% 23.69% 23.54% 43.42% 12.71% 7.77% 15.07% 10.08% 28.30%
Operating Expenses to Revenue		 66.21% 68.93% 85.09% 71.58% 71.62% 140.79% 47.59% 37.76% 59.18% 39.09% 80.69%
Earnings before Interest and Taxes (EBIT)		 -0.22 -0.36 -3.72 -2.01 -1.97 -7.65 4.12 28 -0.34 8.09 -10
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 0.09 -0.03 -3.33 -1.35 -1.42 -6.92 4.73 28 0.12 8.52 -9.68
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 4.13 5.85 3.95 2.05 2.95 4.58 2.57 0.79 2.03 1.35
Price to Tangible Book Value (P/TBV)		 0.00 4.31 6.13 4.02 2.08 3.00 4.61 2.57 0.79 2.03 1.35
Price to Revenue (P/Rev)		 0.00 4.26 3.32 3.96 2.11 6.62 4.41 2.77 1.57 2.71 2.36
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 28.93 5.45 79.15 17.03 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.46% 18.33% 1.26% 5.87% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 18.96 21.93 8.05 3.35 7.12 9.07 4.22 0.59 2.70 1.65
Enterprise Value to Revenue (EV/Rev)		 0.00 3.41 2.88 3.38 1.54 5.10 3.87 2.21 0.62 2.18 1.56
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 22.12 3.46 125.95 10.70 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 25.42 3.52 0.00 11.27 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 25.41 7.68 0.00 15.29 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 81.25
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 97.24 0.00 0.00 79.28
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.07 0.00 0.19 0.00 0.00 0.01 0.00 0.02 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.19 0.00 0.00 0.01 0.00 0.02 0.00 0.00 0.00
Financial Leverage		 -0.78 -0.81 -0.80 -0.64 -0.57 -0.61 -0.61 -0.53 -0.49 -0.43 -0.42
Leverage Ratio		 1.63 1.35 1.40 1.37 1.29 1.31 1.27 1.20 1.14 1.11 1.11
Compound Leverage Factor		 1.75 1.29 1.40 1.38 1.11 1.17 1.27 1.20 -2.19 1.23 1.04
Debt to Total Capital		 6.66% 0.00% 15.94% 0.00% 0.00% 1.23% 0.20% 1.70% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 6.66% 0.00% 0.00% 0.00% 0.00% 0.00% 0.20% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 15.94% 0.00% 0.00% 1.23% 0.00% 1.70% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 93.34% 100.00% 84.06% 100.00% 100.00% 98.77% 99.80% 98.30% 100.00% 100.00% 100.00%
Debt to EBITDA		 4.48 0.00 -0.67 0.00 0.00 -0.04 0.01 0.03 0.00 0.00 0.00
Net Debt to EBITDA		 -49.21 0.00 2.70 0.00 0.00 2.11 -3.06 -0.87 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 -0.67 0.00 0.00 -0.04 0.00 0.03 0.00 0.00 0.00
Debt to NOPAT		 -2.73 0.00 -0.85 0.00 0.00 -0.05 0.01 0.06 0.00 0.00 0.00
Net Debt to NOPAT		 29.97 0.00 3.45 0.00 0.00 2.54 -3.51 -1.92 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 -0.85 0.00 0.00 -0.05 0.00 0.06 0.00 0.00 0.00
Altman Z-Score		 0.00 11.29 6.14 10.20 4.74 5.05 12.91 12.07 6.35 13.10 8.85
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.34 4.58 3.68 5.30 5.26 5.18 5.24 6.92 11.76 9.64 9.72
Quick Ratio		 1.95 3.99 3.32 4.73 4.56 3.85 4.47 5.56 8.02 7.10 5.96
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -1.64 -2.64 -9.78 -2.81 -0.11 -0.57 1.01 -2.60 -2.12 0.54
Operating Cash Flow to CapEx		 -682.68% -1,346.87% -1,062.82% -1,001.80% -525.88% -120.89% 0.00% 0.00% -1,147.06% -301.09% 269.39%
Free Cash Flow to Firm to Interest Expense		 0.00 -75.02 -38.35 -62.43 0.00 0.00 -285.50 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 -75.30 -176.16 -44.38 -54.66 0.00 0.00 -143.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -86.33 -189.24 -48.55 -60.11 0.00 0.00 -78.50 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.07 1.04 1.09 1.01 0.78 0.30 0.90 1.00 0.44 0.72 0.48
Accounts Receivable Turnover		 4.96 5.73 5.11 2.92 2.01 1.08 3.40 3.03 1.75 2.75 2.13
Inventory Turnover		 3.70 4.41 5.60 6.80 4.20 1.17 3.25 5.67 1.35 1.58 1.27
Fixed Asset Turnover		 32.03 39.28 49.76 41.13 27.63 7.86 25.39 44.24 28.66 33.98 13.83
Accounts Payable Turnover		 1.60 1.96 1.99 2.06 1.95 1.13 2.90 3.11 2.49 4.57 3.83
Days Sales Outstanding (DSO)		 73.60 63.71 71.42 125.02 181.79 338.95 107.35 120.61 208.96 132.60 171.14
Days Inventory Outstanding (DIO)		 98.73 82.84 65.23 53.70 86.98 313.06 112.29 64.41 271.01 230.62 288.21
Days Payable Outstanding (DPO)		 228.07 186.34 183.64 177.09 187.00 322.72 125.83 117.30 146.67 79.86 95.30
Cash Conversion Cycle (CCC)		 -55.74 -39.80 -46.99 1.64 81.76 329.28 93.80 67.72 333.30 283.36 364.06
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1.28 2.67 2.71 11 13 6.86 12 23 26 34 26
Invested Capital Turnover		 8.03 7.51 7.67 3.83 2.31 0.99 2.94 2.55 0.99 1.41 0.92
Increase / (Decrease) in Invested Capital		 0.00 1.39 0.04 8.38 1.43 -5.66 4.69 12 2.32 8.08 -7.76
Enterprise Value (EV)		 0.00 51 59 89 42 49 105 99 15 91 43
Market Capitalization		 0.00 63 68 105 57 63 119 123 38 113 65
Book Value per Share		 $0.60 $1.13 $0.87 $1.65 $1.70 $1.30 $1.57 $2.89 $2.98 $3.42 $2.93
Tangible Book Value per Share		 $0.53 $1.08 $0.83 $1.62 $1.68 $1.28 $1.56 $2.89 $2.98 $3.42 $2.93
Total Capital		 6.34 15 14 26 28 22 26 49 49 56 48
Total Debt		 0.42 0.00 2.21 0.00 0.00 0.27 0.05 0.83 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 2.21 0.00 0.00 0.27 0.00 0.83 0.00 0.00 0.00
Net Debt		 -4.64 -13 -8.98 -15 -15 -15 -14 -25 -23 -22 -22
Capital Expenditures (CapEx)		 0.20 0.29 0.29 0.85 0.40 0.36 -0.13 -15 0.19 0.28 0.20
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.26 1.60 1.83 11 12 5.41 11 20 22 29 19
Debt-free Net Working Capital (DFNWC)		 5.32 13 13 26 28 20 25 46 45 51 41
Net Working Capital (NWC)		 4.90 13 13 26 28 20 25 46 45 51 41
Net Nonoperating Expense (NNE)		 0.08 0.09 1.11 0.62 0.32 1.07 0.00 -11 -0.77 -0.69 0.50
Net Nonoperating Obligations (NNO)		 -4.64 -13 -8.98 -15 -15 -15 -14 -25 -23 -22 -22
Total Depreciation and Amortization (D&A)		 0.32 0.34 0.39 0.66 0.55 0.72 0.61 0.51 0.46 0.43 0.63
Debt-free, Cash-free Net Working Capital to Revenue		 2.50% 10.79% 8.89% 39.74% 44.18% 56.47% 39.99% 44.97% 90.83% 68.88% 69.45%
Debt-free Net Working Capital to Revenue		 51.81% 88.46% 63.24% 97.92% 101.00% 212.12% 93.68% 102.27% 185.68% 121.64% 149.81%
Net Working Capital to Revenue		 47.69% 88.46% 63.24% 97.92% 101.00% 212.12% 93.49% 102.27% 185.68% 121.64% 149.81%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.08) ($0.03) ($0.28) ($0.14) ($0.10) ($0.42) $0.25 $1.47 $0.03 $0.41 ($0.47)
Adjusted Weighted Average Basic Shares Outstanding		 9.89M 13.53M 13.54M 16.40M 16.49M 16.49M 16.48M 16.48M 16.26M 16.31M 16.33M
Adjusted Diluted Earnings per Share		 ($0.08) ($0.03) ($0.28) ($0.14) ($0.10) ($0.42) $0.25 $1.46 $0.03 $0.41 ($0.47)
Adjusted Weighted Average Diluted Shares Outstanding		 9.89M 13.53M 13.54M 16.40M 16.49M 16.49M 16.50M 16.62M 16.27M 16.36M 16.33M
Adjusted Basic & Diluted Earnings per Share		 ($0.08) ($0.03) ($0.28) ($0.14) ($0.10) ($0.42) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 9.89M 12.03M 13.24M 14.12M 16.23M 16.43M 16.66M 16.40M 16.39M 16.50M 16.46M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.15 -0.25 -2.60 -1.40 -1.38 -5.76 2.88 1.78 -0.28 5.96 -7.21
Normalized NOPAT Margin		 -1.51% -1.72% -12.64% -5.31% -5.05% -60.18% 10.67% 3.99% -1.16% 14.26% -26.25%
Pre Tax Income Margin		 -2.31% -2.34% -18.02% -7.65% -6.24% -71.38% 15.23% 62.85% 2.67% 21.58% -35.02%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -12.44 -16.61 -53.97 -12.80 0.00 0.00 2,059.50 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 -8.71 -11.62 -37.78 -8.96 0.00 0.00 2,060.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -23.47 -29.68 -58.14 -18.25 0.00 0.00 2,124.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -19.74 -24.70 -41.95 -14.41 0.00 0.00 2,124.50 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% -736.82% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -78.31% -1,350.64% 0.00% -69.33% 0.00% 0.00% 0.00% 12.37% 5.57% 0.00% -3.89%

Quarterly Metrics And Ratios for Sensus Healthcare

This table displays calculated financial ratios and metrics derived from Sensus Healthcare's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 16,391,831.00 16,382,404.00 16,382,404.00 16,382,404.00 16,382,404.00 16,382,404.00 16,495,396.00 16,445,036.00 16,440,036.00 16,425,036.00 16,462,059.00
DEI Adjusted Shares Outstanding		 16,391,831.00 16,382,404.00 16,382,404.00 16,382,404.00 16,382,404.00 16,382,404.00 16,495,396.00 16,445,036.00 16,440,036.00 16,425,036.00 16,462,059.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.09 0.26 0.14 0.10 0.07 0.09 -0.16 -0.06 -0.06 -0.19 -0.16
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -56.74% -4.11% 212.33% 104.09% 126.76% 3.98% -21.75% -20.82% -22.12% -62.20% -59.32%
EBITDA Growth		 -174.21% 32.49% 206.64% 306.21% 191.41% -67.28% -183.23% -186.65% -250.91% -260.48% -67.93%
EBIT Growth		 -181.31% 33.79% 198.23% 275.87% 180.68% -69.06% -191.65% -198.03% -271.84% -282.45% -64.70%
NOPAT Growth		 -176.49% 51.12% 202.91% 284.84% 177.19% -66.28% -187.49% -193.27% -275.63% -261.58% -64.70%
Net Income Growth		 -179.33% 48.82% 220.06% 524.21% 183.74% -63.28% -213.10% -164.33% -177.61% -304.85% -2.10%
EPS Growth		 0.00% 0.00% 216.67% 600.00% 177.78% -61.54% -214.29% -160.00% -185.71% -290.00% 0.00%
Operating Cash Flow Growth		 -88.13% 126.38% -36.52% 470.08% 794.34% -131.00% 67.30% -26.31% -41.94% -166.87% -40.19%
Free Cash Flow Firm Growth		 -354.78% 118.90% 59.15% 57.71% 59.39% -487.93% 115.36% 140.94% 147.04% 182.70% 203.53%
Invested Capital Growth		 152.44% 9.90% 37.24% 30.71% 31.01% 31.44% -8.29% -11.87% -15.30% -22.97% -19.87%
Revenue Q/Q Growth		 -13.89% 222.37% -15.14% -13.35% -4.33% 47.82% -36.14% -12.33% -5.89% -28.25% -31.28%
EBITDA Q/Q Growth		 -74.87% 425.42% -47.14% -31.45% -22.48% 16.47% -234.46% 28.63% -35.01% -23.86% -40.70%
EBIT Q/Q Growth		 -64.42% 401.08% -48.25% -31.35% -24.57% 15.45% -253.30% 26.57% -32.22% -22.58% -38.39%
NOPAT Q/Q Growth		 -68.15% 404.97% -47.67% -31.12% -29.78% 33.23% -235.77% 26.57% -32.22% -22.58% -38.39%
Net Income Q/Q Growth		 -281.84% 390.14% -45.99% -29.11% -24.63% 27.24% -266.36% 59.68% 9.06% -235.84% 17.08%
EPS Q/Q Growth		 -350.00% 388.89% -46.15% -28.57% -30.00% 42.86% -260.00% 62.50% 0.00% -216.67% 15.79%
Operating Cash Flow Q/Q Growth		 -40.43% 503.62% -406.86% 151.67% -6.55% -120.92% -223.70% 216.44% -26.37% -196.17% -70.05%
Free Cash Flow Firm Q/Q Growth		 -3.09% 110.90% -558.33% 17.87% 0.99% -4.09% 118.14% 118.99% 13.75% 83.00% -33.42%
Invested Capital Q/Q Growth		 -7.15% 6.61% 44.13% -8.38% -6.94% 6.96% 0.57% -11.95% -10.57% -2.71% 4.61%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 51.03% 62.31% 62.48% 58.70% 59.28% 54.39% 52.18% 39.69% 39.41% 38.41% 29.20%
EBITDA Margin		 -44.82% 45.24% 28.18% 22.30% 18.07% 14.24% -29.97% -24.40% -35.01% -60.44% -123.75%
Operating Margin		 -48.61% 44.40% 27.07% 21.45% 16.91% 13.21% -31.71% -26.56% -37.32% -63.76% -128.40%
EBIT Margin		 -47.54% 44.40% 27.07% 21.45% 16.91% 13.21% -31.71% -26.56% -37.32% -63.76% -128.40%
Profit (Net Income) Margin		 -37.22% 33.50% 21.33% 17.45% 13.75% 11.83% -30.82% -14.18% -13.70% -64.12% -77.37%
Tax Burden Percent		 92.07% 72.51% 73.33% 73.57% 68.49% 79.04% 104.47% 58.92% 39.14% 105.81% 62.04%
Interest Burden Percent		 85.05% 104.07% 107.41% 110.54% 118.66% 113.33% 93.05% 90.58% 93.77% 95.05% 97.13%
Effective Tax Rate		 0.00% 27.49% 26.67% 26.43% 31.51% 20.96% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -50.45% 32.02% 19.63% 19.17% 17.19% 14.68% -24.69% -21.88% -31.90% -41.03% -66.21%
ROIC Less NNEP Spread (ROIC-NNEP)		 -50.03% 31.33% 18.70% 18.38% 16.30% 13.88% -20.36% -23.46% -35.54% -36.67% -68.48%
Return on Net Nonoperating Assets (RNNOA)		 31.67% -15.47% -6.43% -7.25% -7.11% -5.99% 6.49% 9.19% 15.86% 15.57% 25.98%
Return on Equity (ROE)		 -18.78% 16.55% 13.21% 11.92% 10.08% 8.69% -18.20% -12.69% -16.04% -25.46% -40.23%
Cash Return on Invested Capital (CROIC)		 -93.96% -10.59% -19.12% -6.69% 4.19% -7.12% 12.40% 9.62% 3.53% 1.81% -5.45%
Operating Return on Assets (OROA)		 -22.52% 19.62% 15.49% 14.16% 12.66% 9.53% -21.32% -17.05% -22.49% -30.42% -51.78%
Return on Assets (ROA)		 -17.63% 14.81% 12.20% 11.52% 10.29% 8.54% -20.72% -9.10% -8.26% -30.59% -31.20%
Return on Common Equity (ROCE)		 -18.78% 16.55% 13.21% 11.92% 10.08% 8.69% -18.20% -12.69% -16.04% -25.46% -40.23%
Return on Equity Simple (ROE_SIMPLE)		 -2.01% 0.00% 9.09% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -1.33 4.05 2.12 1.46 1.02 1.36 -1.85 -1.36 -1.80 -2.20 -3.05
NOPAT Margin		 -34.03% 32.19% 19.85% 15.78% 11.58% 10.44% -22.20% -18.59% -26.12% -44.63% -89.88%
Net Nonoperating Expense Percent (NNEP)		 -0.43% 0.69% 0.94% 0.79% 0.89% 0.80% -4.33% 1.57% 3.64% -4.36% 2.27%
Return On Investment Capital (ROIC_SIMPLE)		 - 8.28% 4.09% 2.76% 1.89% 2.44% -3.49% -2.61% -3.51% -4.58% -6.70%
Cost of Revenue to Revenue		 48.97% 37.69% 37.52% 41.30% 40.72% 45.61% 47.82% 60.31% 60.59% 61.59% 70.80%
SG&A Expenses to Revenue		 38.76% 7.58% 14.81% 17.09% 17.80% 18.49% 26.46% 27.15% 27.85% 35.68% 60.19%
R&D to Revenue		 27.78% 5.37% 8.68% 9.37% 9.76% 11.95% 31.23% 20.11% 26.42% 38.10% 46.85%
Operating Expenses to Revenue		 99.64% 17.91% 35.40% 37.24% 42.37% 41.18% 83.89% 66.25% 76.73% 102.17% 157.60%
Earnings before Interest and Taxes (EBIT)		 -1.85 5.58 2.89 1.98 1.50 1.73 -2.65 -1.94 -2.57 -3.15 -4.36
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -1.75 5.69 3.01 2.06 1.60 1.86 -2.50 -1.79 -2.41 -2.99 -4.20
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.01 0.79 1.21 1.65 1.75 2.03 1.46 1.49 1.00 1.35 1.44
Price to Tangible Book Value (P/TBV)		 1.01 0.79 1.21 1.65 1.75 2.03 1.46 1.49 1.00 1.35 1.44
Price to Revenue (P/Rev)		 1.81 1.57 1.96 2.39 2.30 2.71 1.96 2.06 1.44 2.36 2.91
Price to Earnings (P/E)		 0.00 79.15 13.33 13.10 10.18 17.03 42.92 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 1.26% 7.50% 7.63% 9.82% 5.87% 2.33% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.02 0.59 1.29 2.01 2.29 2.70 1.71 1.85 1.00 1.65 1.73
Enterprise Value to Revenue (EV/Rev)		 0.99 0.62 1.51 1.87 1.75 2.18 1.47 1.47 0.75 1.56 2.09
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 125.95 8.10 7.60 5.85 10.70 19.31 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 8.79 7.96 6.05 11.27 22.77 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 12.18 11.41 8.36 15.29 43.73 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 27.12 0.00 12.44 15.48 14.04 81.25 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 61.96 0.00 13.23 17.98 26.02 79.28 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.63 -0.49 -0.34 -0.39 -0.44 -0.43 -0.32 -0.39 -0.45 -0.42 -0.38
Leverage Ratio		 1.15 1.14 1.13 1.11 1.12 1.11 1.13 1.11 1.12 1.11 1.13
Compound Leverage Factor		 0.98 1.19 1.22 1.23 1.33 1.25 1.05 1.01 1.05 1.05 1.10
Debt to Total Capital		 0.00% 0.00% 1.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 1.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 98.93% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.09 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 -2.40 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.09 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 -3.61 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 5.95 6.72 8.09 11.95 11.98 12.77 8.17 8.53 5.90 9.30 7.64
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 8.77 11.76 9.85 11.63 10.52 9.64 8.06 8.14 7.38 9.72 7.27
Quick Ratio		 5.23 8.02 6.28 7.96 7.59 7.10 5.52 5.42 4.97 5.96 3.74
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -16 1.73 -7.93 -6.51 -6.45 -6.71 1.22 2.67 3.03 5.55 3.70
Operating Cash Flow to CapEx		 4,018.18% 0.00% -3,513.73% 141,000.00% 1,173.00% 0.00% -38,242.86% 11,544.44% 57,375.00% -1,396.84% -125,100.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.47 0.44 0.57 0.66 0.75 0.72 0.67 0.64 0.60 0.48 0.40
Accounts Receivable Turnover		 3.49 1.75 1.96 2.65 3.46 2.75 2.10 2.43 2.71 2.13 2.09
Inventory Turnover		 1.33 1.35 1.19 1.26 1.28 1.58 1.41 1.43 1.48 1.27 1.06
Fixed Asset Turnover		 29.09 28.66 36.05 67.41 28.73 33.98 19.56 21.93 17.13 13.83 9.03
Accounts Payable Turnover		 2.33 2.49 2.91 4.00 4.05 4.57 3.72 4.15 3.86 3.83 2.72
Days Sales Outstanding (DSO)		 104.47 208.96 186.56 137.72 105.35 132.60 173.97 150.20 134.78 171.14 174.92
Days Inventory Outstanding (DIO)		 273.86 271.01 306.18 288.98 284.39 230.62 258.99 255.79 246.26 288.21 343.76
Days Payable Outstanding (DPO)		 156.40 146.67 125.47 91.17 90.07 79.86 98.14 87.88 94.46 95.30 134.35
Cash Conversion Cycle (CCC)		 221.93 333.30 367.27 335.52 299.66 283.36 334.82 318.11 286.58 364.06 384.32
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 24 26 37 34 32 34 34 30 27 26 27
Invested Capital Turnover		 1.48 0.99 0.99 1.21 1.48 1.41 1.11 1.18 1.22 0.92 0.74
Increase / (Decrease) in Invested Capital		 15 2.32 10 7.97 7.47 8.08 -3.07 -4.03 -4.83 -7.76 -6.75
Enterprise Value (EV)		 25 15 48 68 72 91 58 55 27 43 47
Market Capitalization		 45 38 62 87 95 113 77 77 51 65 66
Book Value per Share		 $2.72 $2.98 $3.14 $3.25 $3.32 $3.42 $3.22 $3.17 $3.11 $2.93 $2.77
Tangible Book Value per Share		 $2.72 $2.98 $3.14 $3.25 $3.32 $3.42 $3.22 $3.17 $3.11 $2.93 $2.77
Total Capital		 45 49 52 53 54 56 53 52 51 48 46
Total Debt		 0.00 0.00 0.55 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.55 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -20 -23 -14 -19 -23 -22 -19 -22 -24 -22 -18
Capital Expenditures (CapEx)		 0.01 0.00 0.23 0.00 0.34 -0.30 0.01 0.03 0.00 0.16 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 20 22 34 31 27 29 28 24 19 19 18
Debt-free Net Working Capital (DFNWC)		 41 45 48 50 50 51 47 46 43 41 37
Net Working Capital (NWC)		 41 45 48 50 50 51 47 46 43 41 37
Net Nonoperating Expense (NNE)		 0.12 -0.16 -0.16 -0.15 -0.19 -0.18 0.72 -0.32 -0.86 0.96 -0.42
Net Nonoperating Obligations (NNO)		 -20 -23 -14 -19 -23 -22 -19 -22 -24 -22 -18
Total Depreciation and Amortization (D&A)		 0.11 0.11 0.12 0.08 0.10 0.13 0.15 0.16 0.16 0.16 0.16
Debt-free, Cash-free Net Working Capital to Revenue		 80.74% 90.83% 106.50% 84.75% 65.46% 68.88% 71.92% 62.94% 53.21% 69.45% 81.68%
Debt-free Net Working Capital to Revenue		 162.88% 185.68% 153.03% 136.92% 120.07% 121.64% 120.22% 121.94% 121.88% 149.81% 163.02%
Net Working Capital to Revenue		 162.88% 185.68% 153.03% 136.92% 120.07% 121.64% 120.22% 121.94% 121.88% 149.81% 163.02%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.09) $0.26 $0.14 $0.10 $0.07 $0.10 ($0.16) ($0.06) ($0.06) ($0.19) ($0.16)
Adjusted Weighted Average Basic Shares Outstanding		 16.27M 16.26M 16.29M 16.30M 16.32M 16.31M 16.34M 16.32M 16.32M 16.33M 16.46M
Adjusted Diluted Earnings per Share		 $0.00 $0.26 $0.14 $0.10 $0.07 $0.10 ($0.16) ($0.06) ($0.06) ($0.19) ($0.16)
Adjusted Weighted Average Diluted Shares Outstanding		 16.27M 16.27M 16.32M 16.33M 16.35M 16.36M 16.34M 16.32M 16.32M 16.33M 16.46M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 16.38M 16.39M 16.39M 16.39M 0.00 16.50M 16.45M 16.44M 16.43M 16.46M 16.46M
Normalized Net Operating Profit after Tax (NOPAT)		 -1.33 4.05 2.12 1.46 1.02 1.36 -1.85 -1.36 -1.80 -2.20 -3.05
Normalized NOPAT Margin		 -34.03% 32.19% 19.85% 15.78% 11.58% 10.44% -22.20% -18.59% -26.12% -44.63% -89.88%
Pre Tax Income Margin		 -40.43% 46.20% 29.08% 23.71% 20.07% 14.97% -29.51% -24.06% -34.99% -60.60% -124.72%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -225.56% 5.57% 0.00% 0.00% 0.50% 0.00% 16.66% -35.38% -8.42% -3.89% 0.00%

Financials Breakdown Chart

Sensus Healthcare Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Sensus Healthcare's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Sensus Healthcare's net income appears to be on an upward trend, with a most recent value of -$7.72 million in 2025, rising from -$237.27 thousand in 2015. The previous period was $6.65 million in 2024. Check out Sensus Healthcare's forecast to explore projected trends and price targets.

Sensus Healthcare's total operating income in 2025 was -$10.31 million, based on the following breakdown:
  • Total Gross Profit: $11.87 million
  • Total Operating Expenses: $22.17 million

Over the last 10 years, Sensus Healthcare's total revenue changed from $10.27 million in 2015 to $27.48 million in 2025, a change of 167.5%.

Sensus Healthcare's total liabilities were at $4.94 million at the end of 2025, a 22.0% decrease from 2024, and a 33.0% increase since 2015.

In the past 10 years, Sensus Healthcare's cash and equivalents has ranged from $5.04 million in 2016 to $25.52 million in 2022, and is currently $22.08 million as of their latest financial filing in 2025.

Over the last 10 years, Sensus Healthcare's book value per share changed from 0.60 in 2015 to 2.93 in 2025, a change of 388.9%.


Related Companies

Financial statements for NASDAQ:SRTS last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel